Log in or Sign up for Free to view tailored content for your specialty!
Drug/Insect/Latex News
Symptoms resolve with dupilumab in patients with drug reactions
Dupilumab may be a safe and effective therapy for patients with drug reactions with eosinophilia and systemic symptoms, or DRESS, according to a case series published in The Journal of Allergy and Clinical Immunology: In Practice.
Case study of boy with fire ant allergy illustrates barriers in access to immunotherapy
The obstacles that a boy with a fire ant allergy faced in accessing immunotherapy exemplify barriers to care in underserved populations, according to a case study published in The Journal of Allergy and Clinical Immunology: In Practice.
Log in or Sign up for Free to view tailored content for your specialty!
Exacerbations follow COVID-19 vaccination in minority of patients with chronic urticaria
A minority of patients with chronic urticaria experienced exacerbations after COVID-19 vaccination, with rare systemic reactions, according to a study published in The Journal of Allergy and Clinical Immunology.
Testing options for insect venom allergies depend on patient evaluations
PARK CITY, Utah — Patients who have had systemic reactions to insect stings should be evaluated, including education and testing, according to a presentation here.
Q&A: Drug allergy diagnosis project could ‘touch every single specialty’
Drug allergy diagnosis could become more precise, cutting down on mislabeled allergies and needless drug avoidance, as a result of upcoming work comparing different types of drug hypersensitivity reactions.
Patients with delayed cutaneous reactions to COVID-19 vaccine tolerate subsequent doses
Most patients who had a delayed immune-mediated adverse event following COVID-19 vaccination tolerated revaccination, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Direct oral challenges rival standard of care in assessing low-risk penicillin allergy
Direct oral challenges in adults at low risk for penicillin allergy were safe and not inferior to the standard-of-care oral challenge following two-stage skin testing, according to a study published in JAMA Internal Medicine.
VIDEO: Second day of physician assistant conference highlights asthma, allergy topics
PARK CITY, Utah — Bee stings and a good night’s rest were on the agenda, among other topics, during the second day of the Association of PAs in Allergy, Asthma and Immunology Annual Allergy, Asthma & Immunology CME Conference.
Sublingual immunotherapy improves bronchial epithelial antiviral resistance
Sublingual immunotherapy for house dust mite allergic asthma improved bronchial epithelial antiviral resistance to viral infection, according to a study published in the American Journal of Respiratory and Critical Care Medicine.
Cell protein triggers reactions by binding with house dust mite allergens
A cell protein known as LMAN1 plays a role in responses to house dust mite, opening potential avenues for new treatments for these and other allergies, according to a study published in Cell Reports.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read